List of Tables
    Table 1. Fibromyalgia Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Fibromyalgia Drugs Market Trends
    Table 3. Fibromyalgia Drugs Market Drivers
    Table 4. Fibromyalgia Drugs Market Challenges
    Table 5. Fibromyalgia Drugs Market Restraints
    Table 6. Global Fibromyalgia Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Fibromyalgia Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Fibromyalgia Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Fibromyalgia Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Fibromyalgia Drugs Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Fibromyalgia Drugs Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Fibromyalgia Drugs Revenue Share by Player, 2017-2022
    Table 13. Global Fibromyalgia Drugs Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Fibromyalgia Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Drugs as of 2021)
    Table 15. Top Players of Fibromyalgia Drugs in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Fibromyalgia Drugs Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Fibromyalgia Drugs Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Fibromyalgia Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Fibromyalgia Drugs Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Fibromyalgia Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Fibromyalgia Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Fibromyalgia Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Fibromyalgia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Fibromyalgia Drugs Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Fibromyalgia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Fibromyalgia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Fibromyalgia Drugs Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Fibromyalgia Drugs Product
    Table 33. Pfizer Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Eli Lilly Company Details
    Table 36. Eli Lilly Business Overview
    Table 37. Eli Lilly Fibromyalgia Drugs Product
    Table 38. Eli Lilly Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 39. Eli Lilly Recent Development
    Table 40. Actavis Company Details
    Table 41. Actavis Business Overview
    Table 42. Actavis Fibromyalgia Drugs Product
    Table 43. Actavis Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 44. Actavis Recent Development
    Table 45. Merck Sharp and Dohme Company Details
    Table 46. Merck Sharp and Dohme Business Overview
    Table 47. Merck Sharp and Dohme Fibromyalgia Drugs Product
    Table 48. Merck Sharp and Dohme Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 49. Merck Sharp and Dohme Recent Development
    Table 50. Daiichi Sankyo Company Details
    Table 51. Daiichi Sankyo Business Overview
    Table 52. Daiichi Sankyo Fibromyalgia Drugs Product
    Table 53. Daiichi Sankyo Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 54. Daiichi Sankyo Recent Development
    Table 55. Innovative Med Concepts Company Details
    Table 56. Innovative Med Concepts Business Overview
    Table 57. Innovative Med Concepts Fibromyalgia Drugs Product
    Table 58. Innovative Med Concepts Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 59. Innovative Med Concepts Recent Development
    Table 60. Meda Company Details
    Table 61. Meda Business Overview
    Table 62. Meda Fibromyalgia Drugs Product
    Table 63. Meda Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 64. Meda Recent Development
    Table 65. Meiji Seika Company Details
    Table 66. Meiji Seika Business Overview
    Table 67. Meiji Seika Fibromyalgia Drugs Product
    Table 68. Meiji Seika Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 69. Meiji Seika Recent Development
    Table 70. Switch Biotech Company Details
    Table 71. Switch Biotech Business Overview
    Table 72. Switch Biotech Fibromyalgia Drugs Product
    Table 73. Switch Biotech Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 74. Switch Biotech Recent Development
    Table 75. Theravance Company Details
    Table 76. Theravance Business Overview
    Table 77. Theravance Fibromyalgia Drugs Product
    Table 78. Theravance Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 79. Theravance Recent Development
    Table 80. Zynerba Pharmaceuticals Company Details
    Table 81. Zynerba Pharmaceuticals Business Overview
    Table 82. Zynerba Pharmaceuticals Fibromyalgia Drugs Product
    Table 83. Zynerba Pharmaceuticals Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 84. Zynerba Pharmaceuticals Recent Development
    Table 85. Tonix Pharmaceuticals Holding Corp. (TNXP) Company Details
    Table 86. Tonix Pharmaceuticals Holding Corp. (TNXP) Business Overview
    Table 87. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Drugs Product
    Table 88. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue in Fibromyalgia Drugs Business (2017-2022) & (US$ Million)
    Table 89. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Fibromyalgia Drugs Product Picture
    Figure 2. Global Fibromyalgia Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Fibromyalgia Drugs Market Size 2017-2028 (US$ Million)
    Figure 4. United States Fibromyalgia Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Fibromyalgia Drugs Market Size 2017-2028 (US$ Million)
    Figure 6. United States Fibromyalgia Drugs Market Share in Global 2017-2028
    Figure 7. Fibromyalgia Drugs Report Years Considered
    Figure 8. Product Picture of Serotonin Norepinephrine Reuptake Inhibitors
    Figure 9. Product Picture of GABA Analogs
    Figure 10. Product Picture of Other
    Figure 11. Global Fibromyalgia Drugs Market Share by Type in 2022 & 2028
    Figure 12. Global Fibromyalgia Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Fibromyalgia Drugs Market Share by Type (2017-2028)
    Figure 14. United States Fibromyalgia Drugs Market Share by Type in 2022 & 2028
    Figure 15. United States Fibromyalgia Drugs Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Fibromyalgia Drugs Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospitals
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Other
    Figure 20. Global Fibromyalgia Drugs Market Share by Application in 2022 & 2028
    Figure 21. Global Fibromyalgia Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 22. Global Fibromyalgia Drugs Market Share by Application (2017-2028)
    Figure 23. United States Fibromyalgia Drugs Market Share by Application in 2022 & 2028
    Figure 24. United States Fibromyalgia Drugs Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. United States Fibromyalgia Drugs Market Share by Application (2017-2028)
    Figure 26. North America Fibromyalgia Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 27. U.S. Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Canada Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Europe Fibromyalgia Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. Germany Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. France Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. U.K. Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Italy Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Russia Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Fibromyalgia Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 36. China Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Japan Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. South Korea Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. India Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Australia Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Taiwan Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Indonesia Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Thailand Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Malaysia Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Philippines Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Latin America Fibromyalgia Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 47. Mexico Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Brazil Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Argentina Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Fibromyalgia Drugs Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 51. Turkey Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. UAE Fibromyalgia Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Pfizer Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 55. Eli Lilly Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 56. Actavis Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 57. Merck Sharp and Dohme Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 58. Daiichi Sankyo Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 59. Innovative Med Concepts Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 60. Meda Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 61. Meiji Seika Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 62. Switch Biotech Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 63. Theravance Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 64. Zynerba Pharmaceuticals Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 65. Tonix Pharmaceuticals Holding Corp. (TNXP) Revenue Growth Rate in Fibromyalgia Drugs Business (2017-2022)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed